🟢 Eupraxia Pharmaceuticals is trading 10.53% up today with no confirmed catalyst identified

Eupraxia Pharmaceuticals is trading at $8.29, up +10.53% on September 4, 2026, with no confirmed company-specific catalyst identified.

• The Nasdaq Global Market listing transfer became effective September 3, 2026, though available coverage does not explicitly link it to the move.
• Broader U.S. markets are lower, so market-wide sentiment does not clearly explain the opposite-direction gain.
• Confidence remains low pending further disclosures.